Altaris Capital Partners is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris Capital Partners was formed in 2004 and is based in New York City.
Join Mergr to view the latest updates and news from New York-based Altaris Capital Partners.
In the last 3 years, Altaris Capital Partners has acquired 1 company.
Altaris Capital Partners’ most common sectors for investment are medical products (53%) and healthcare services (22%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (32%) and secondary buyout (27%). In total, Altaris Capital Partners has invested in 12 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2018 when it acquired Analogic for $1.1B.
In the last 3 years, Altaris Capital Partners has exited 5 companies. The Firm’s most common exit type is secondary buyout (48%). Altaris Capital Partners’ largest (disclosed) exit occurred in 2011 when it sold Specialty Care for $2.3B.
Join Mergr to view Altaris Capital Partners’ full profile and discover more large private equity firms just like it.
No obligation. Cancel anytime.